MedTrace Logo

Cardiovascular Protection After Preeclampsia With Enalapril

NCT07222852 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-10-30

No results posted yet for this study

Summary

The purpose of this study is to learn if postpartum women are willing to be randomized to different blood pressure medicines after delivery and how that affects blood pressure in women with hypertensive disorders of pregnancy.

Conditions

  • Preeclampsia
  • Hypertensive Disorder of Pregnancy
  • Hypertension
  • Gestational Hypertension
  • Gestational Hypertension After Childbirth

Interventions

DRUG

Enalapril

First-line anti-hypertensive treatment with enalapril

OTHER

Standard treatment

First-line anti-hypertensive treatment per standard of care

Sponsors & Collaborators

  • Women and Infants Hospital of Rhode Island

    lead OTHER

Principal Investigators

  • Alisse Hauspurg, MD · WOMEN AND INFANTS HOSPITAL-RHODE ISLAND

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-15
Primary Completion
2027-10-15
Completion
2027-10-15
FDA Drug
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07222852 on ClinicalTrials.gov